Detalles de la búsqueda
1.
Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO study.
Int J Cancer
; 155(1): 128-138, 2024 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38447007
2.
Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical Trial.
Clin Chem
; 70(1): 307-318, 2024 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38175595
3.
Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept.
Ann Surg Oncol
; 31(2): 957-965, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37947974
4.
Relationship of Ki-67 index in biopsies of metastatic breast cancer tissue and circulating tumor cells (CTCs) at the time of biopsy collection.
Arch Gynecol Obstet
; 309(1): 235-248, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37480379
5.
Detection and Isolation of Circulating Tumor Cells from Breast Cancer Patients Using CUB Domain-Containing Protein 1.
J Proteome Res
; 22(4): 1213-1230, 2023 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36926972
6.
Palbociclib with Fulvestrant or Letrozole in Endocrine-Sensitive Patients with HR-Positive/HER2-Negative Advanced Breast Cancer: A Detailed Safety Analysis of the Randomized PARSIFAL Trial.
Oncologist
; 28(1): 23-32, 2023 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36239405
7.
Return of individual genomic research results within the PRAEGNANT multicenter registry study.
Breast Cancer Res Treat
; 197(2): 355-368, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36409394
8.
The INFINITY study protocol: a retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice.
BMC Cancer
; 23(1): 543, 2023 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37312086
9.
Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancer.
Arch Gynecol Obstet
; 307(4): 1105-1113, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35980458
10.
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.
Br J Cancer
; 126(12): 1715-1724, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35194193
11.
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
N Engl J Med
; 380(7): 617-628, 2019 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30516102
12.
Dual HER2 blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T: results from a German non-interventional study (NIS) HELENA (NCT01777958).
Breast Cancer Res Treat
; 196(2): 311-321, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36094611
13.
Stereotactic radiosurgery for brain metastases from pelvic gynecological malignancies: oncologic outcomes, validation of prognostic scores, and dosimetric evaluation.
Int J Gynecol Cancer
; 32(2): 172-180, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34848530
14.
Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective Trial.
J Med Internet Res
; 24(2): e16128, 2022 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35133288
15.
How previous treatment changes the metabolomic profile in patients with metastatic breast cancer.
Arch Gynecol Obstet
; 306(6): 2115-2122, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35467121
16.
Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancer.
Arch Gynecol Obstet
; 306(3): 875-885, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35237856
17.
Circulating miR-200 Family and CTCs in Metastatic Breast Cancer before, during, and after a New Line of Systemic Treatment.
Int J Mol Sci
; 23(17)2022 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36076930
18.
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials.
Lancet Oncol
; 22(8): 1151-1161, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34252375
19.
Preventive effect of sensorimotor exercise and resistance training on chemotherapy-induced peripheral neuropathy: a randomised-controlled trial.
Br J Cancer
; 125(7): 955-965, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34226683
20.
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.
N Engl J Med
; 379(22): 2108-2121, 2018 11 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30345906